Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Studies how adults with type 2 diabetes care for themselves over time

Follows adults with type 2 diabetes to see how self-care relates to blood sugar.

Plain-language title generated from the registry record
Registry title: Self-care Behaviors of Type 2 Diabetes Mellitus Patients

Key facts

Where
Monza and San Donato Milanese, ItalySee the 2 sites

Where in Italy

  • Fondazione IRCCS San Gerardo dei TintoriMonza, ItalyTaking people
  • IRCCS Policlinico San DonatoSan Donato Milanese, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Milano Bicocca
Trial code
NCT07042399
Record updated
29 June 2025
Original description
The goal of this observational study is to explore the experience of the chronic disease, with a particular focus on self-care, in adults with type 2 diabetes mellitus. The main questions it aims to answer are:Read full original descriptionShow less

Self-care Behaviours of Type 2 Diabetes Mellitus Patients: a Multicenter Prospective Observational Study With 2 Years Follow-up (SCUDOS)

The goal of this observational study is to explore the experience of the chronic disease, with a particular focus on self-care, in adults with type 2 diabetes mellitus. The main questions it aims to answer are:

* what is the association between self-care and glycated hemoglobin over time? * what are participants' clinical and sociodemographic characteristics influencing self-care behaviors? Participants' socio-demographic and clinical data will be collected by medical records and, at the beginning or at the end of the clinical standard outpatient visit, they will be asked to complete study questionnaires.

The results of this study could be helpful in providing quality assistance, improving resource consumption, and reducing the onset of complications.

Inclusion: Diagnosis of type 2 diabetes; Age over 18 years old; Adequate comprehension of the Italian language; Signed and dated informed consent.

Exclusion: Presence of documented psychiatric or neurodegenerative disease; Any condition that, by the investigators' judgment, may limit adherence to study procedures; Pregnancy.

ClinicalTrials.gov NCT07042399